1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Epirubicin Market – By Dosage

1.3.2        North America Epirubicin Market – By Application

1.3.3        North America Epirubicin Market – By Distribution Channel

1.3.4        North America Epirubicin Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Epirubicin Market – Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Experts Opinion

5.           North America Epirubicin Market– Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of Cancer

5.1.2        Increasing Awareness Regarding Cancer

5.2         Market Restraints

5.2.1        Elevated Risk of Adverse Effects due to Epirubicin

5.3         Market Opportunities

5.3.1        Rising FDA Approvals for Cancer Drugs

5.4         Future Trends

5.4.1        Increase in Number of Cancer Research Programs

5.5         Impact Analysis

6.           Epirubicin Market– North America Analysis

6.1         North America Epirubicin Market Revenue Forecasts and Analysis

7.           North America Epirubicin Market Analysis – By Dosage

7.1         Overview

7.2         North America Epirubicin Market, by Dosage, 2022 & 2028 (%)

7.3mg/Vial

7.3.1        Overview

7.3.2mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)

7.4mg/Vial

7.4.1        Overview

7.4.2mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)

7.5mg/Vial

7.5.1        Overview

7.5.2mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)

7.6mg/Vial

7.6.1        Overview

7.6.2 Mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)

8.           North America Epirubicin Market Analysis – By Application

8.1         Overview

8.2         North America Epirubicin Market, by Application, 2022 & 2028 (%)

8.3         Breast Cancer

8.3.1        Overview

8.3.2        Breast Cancer Market Revenue and Forecast to 2028 (US$ Thousand)

8.4         Liver Cancer

8.4.1        Overview

8.4.2        Liver Cancer Market Revenue and Forecast to 2028 (US$ Thousand)

8.5         Bladder Cancer

8.5.1        Overview

8.5.2        Bladder Cancer Market Revenue and Forecast to 2028 (US$ Thousand)

8.6         Others

8.6.1        Overview

8.6.2        Others Cancer Market Revenue and Forecast to 2028 (US$ Thousand)

9.           North America Epirubicin Market Analysis – By Distribution Channel

9.1         Overview

9.2         North America Epirubicin Market, by Distribution Channel, 2022 & 2028 (%)

9.3         Hospital Pharmacies

9.3.1        Overview

9.3.2        Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand)

9.4         Retail Pharmacies

9.4.1        Overview

9.4.2        Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand)

9.5         Online Pharmacies

9.5.1        Overview

9.5.2        Online Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand)

10.        North America Epirubicin Market – Country Analysis

10.1      North America: Epirubicin Market

10.1.1     Overview

10.1.2     North America: Epirubicin Market, by Country, 2022 & 2028 (%)

10.1.2.1       US: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)

10.1.2.1.1       Overview

10.1.2.1.2       US: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)

10.1.2.1.3       US: Epirubicin Market, by Dosage, 2019–2028 (US$ Thousand)

10.1.2.1.4       US: Epirubicin Market, by Application, 2019–2028 (US$ Thousand)

10.1.2.1.5       US: Epirubicin Market, by Distribution Channel, 2019–2028 (US$ Thousand)

10.1.2.2       Canada: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)

10.1.2.2.1       Overview

10.1.2.2.2       Canada: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)

10.1.2.2.3       Canada: Epirubicin Market, by Dosage, 2019–2028 (US$ Thousand)

10.1.2.2.4       Canada: Epirubicin Market, by Application, 2019–2028 (US$ Thousand)

10.1.2.2.5       Canada: Epirubicin Market, by Distribution Channel, 2019–2028 (US$ Thousand)

10.1.2.3       Mexico: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)

10.1.2.3.1       Overview

10.1.2.3.2       Mexico: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)

10.1.2.3.3       Mexico: Epirubicin Market, by Dosage, 2019–2028 (US$ Thousand)

10.1.2.3.4       Mexico: Epirubicin Market, by Application, 2019–2028 (US$ Thousand)

10.1.2.3.5       Mexico: Epirubicin Market, by Distribution Channel, 2019–2028 (US$ Thousand)

11.        Industry Landscape

11.1      Overview

11.2      Growth Strategies

11.2.1     Overview

12.        Company Profiles

12.1      Pfizer Inc.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Teva Pharmaceutical Industries Ltd.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Salius Pharma Pvt Ltd

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Areva Pharmaceuticals

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Mylan N.V.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Hikma Pharmaceuticals PLC

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Fresenius Kabi AG

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             North America Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)

Table 2.             US Epirubicin Market, by Dosage – Revenue and Forecast to 2028 (US$ Thousand)

Table 3.             US Epirubicin Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 4.             US Epirubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Thousand)

Table 5.             Canada Epirubicin Market, by Dosage – Revenue and Forecast to 2028 (US$ Thousand)

Table 6.             Canada Epirubicin Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 7.             Canada Epirubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Thousand)

Table 8.             Mexico Epirubicin Market, by Dosage – Revenue and Forecast to 2028 (US$ Thousand)

Table 9.             Mexico Epirubicin Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 10.          Mexico Epirubicin Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Thousand)

Table 11.          Recent Growth Strategies

Table 12.          Glossary of Terms

LIST OF FIGURES

Figure 1.           North America Epirubicin Market Segmentation

Figure 2.           North America Epirubicin Market, By Country

Figure 3.           North America Epirubicin Market Overview

Figure 4.           North America Epirubicin Market, By Dosage

Figure 5.           North America Epirubicin Market, By Country

Figure 6.           North America: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Impact Analysis of Drivers and Restraints on North America Epirubicin Market

Figure 9.           North America Epirubicin Market – Revenue Forecasts and Analysis

Figure 10.        North America Epirubicin Market, by Dosage, 2022 & 2028 (%)

Figure 11.        North America 10mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)

Figure 12.        North America 50mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)

Figure 13.        North America 100mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)

Figure 14.        North America 200 Mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)

Figure 15.        North America Epirubicin Market, by Application, 2022 & 2028 (%)

Figure 16.        North America Breast Cancer Market Revenue and Forecast to 2028 (US$ Thousand)

Figure 17.        North America Liver Cancer Market Revenue and Forecast to 2028 (US$ Thousand)

Figure 18.        North America Bladder Cancer Market Revenue and Forecast to 2028 (US$ Thousand)

Figure 19.        North America Others Cancer Market Revenue and Forecast to 2028 (US$ Thousand)

Figure 20.        North America Epirubicin Market, by Distribution Channel, 2022 & 2028 (%)

Figure 21.        North America Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand)

Figure 22.        North America Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand)

Figure 23.        North America Online Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand)

Figure 24.        North America: Epirubicin Market, by Key Country – Revenue (2022) (US$ Thousand)

Figure 25.        North America: Epirubicin Market, by Country, 2022 & 2028 (%)

Figure 26.        US: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 27.        Canada: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 28.        Mexico: Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)